Previous Article | Next Article ![]()
Molecular and Cellular Biology, October 2004, p. 9221-9238, Vol. 24, No. 20
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.20.9221-9238.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Elizabeth A. Hackett, Yuqi Wang, Henrik G. Dohlman, and Beverly Errede*
Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, North Carolina
Received 22 October 2003/ Returned for modification 1 December 2003/ Accepted 26 July 2004
|
|
|---|
|
|
|---|
Mating is the fusion of two haploid cells of opposite mating types to produce a diploid cell. Differentiation to a mating-competent form is triggered when pheromone from the opposite mating type binds to a G-protein-coupled receptor. The activated G-protein stimulates a MAPK module comprised of the p21 (Cdc42)-associated kinase-Ste20, MAPKKK-Ste11, MAPKK-Ste7, and two MAPKs, Fus3 and Kss1 (Fig. 1) (see reference 12 for review). The scaffold-Ste5 organizes the core enzymes of this pathway by directly binding to Ste11, Ste7, and Fus3 (12). Kss1 does not bind directly to Ste5 but is part of this complex through binding to Ste7 (7). Although Fus3 and Kss1 kinase activities are induced to an equivalent extent in pheromone-treated cells, Fus3, but not Kss1, has specificity for critical substrates, such as Far1, that are dedicated to the mating differentiation response (7, 23, 44). Fus3 and Kss1 are equivalent with respect to promoting a mating-specific transcription program through their activation of the Ste12 transcription factor (7, 41, 57). MAPK activation of Ste12 involves phosphorylation-dependent inactivation of two inhibitors called Rst1 (Dig1) and Rst2 (Dig2) (51). Ste12 functions at mating-specific genes (MSG) either as a homo-multimer at promoters with reiterated pheromone response elements (PREs) or in conjunction with Mcm1 at promoters with P-box elements in proximity to PREs (14, 18) (Fig. 1).
![]() View larger version (33K): [in a new window] |
FIG. 1. Signal transduction pathways with common components mediate two life cycle transitions in haploid S. cerevisiae. See text for explanation.
|
-Gpa2, which together with Ras2 regulates cyclic AMP production and protein kinase A activity (37). The Sho1 and Msb2 transmembrane proteins are upstream regulators of the MAPK-mediated branch of the network (11, 36; P. Cullen and G. F. Sprague, Jr., personal communication). With the exception of Fus3, the same kinases used in the mating pathway comprise the filamentous growth MAPK activation module (Fig. 1) (37). Another notable difference is that there is no known scaffold for the invasive pathway. The Kss1 branch of the pseudohyphal signaling network regulates the filamentation-specific transcription program through activation of the Ste12 transcription factor by phosphorylation-dependent inactivation of the Rst1 (Dig1) and Rst2 (Dig2) inhibitors (5, 9, 51). Ste12 acts at filamentation-specific genes cooperatively with Tec1 at promoters that have a Tec1 consensus binding sequence in proximity to the PRE binding element for Ste12 (6, 31) (Fig. 1). Thus, the transcriptional output for the mating and invasive response depends on the same transcription factor and inhibitor complex, which can be activated by either Kss1 or Fus3. How and whether transcriptional specificity occurs in this circumstance are still poorly understood. Recent evidence from genome-wide location analyses suggests that regulation of Ste12 binding at the different promoters rather than selective activation by the two MAPKs regulates the distinct gene expression programs associated with mating differentiation and filamentous growth (57).
While filamentous growth is persistent, mating differentiation is transient. The transient signal results because cells reenter the cell cycle to resume vegetative growth whether or not mating occurs. Accordingly, the responsiveness of cells to persistent pheromone induction diminishes with time. This phenomenon occurs through several desensitization or adaptation mechanisms that impinge on different components of the signaling pathway upstream of the MAPK activation module (see reference 12 for review). Rapid attenuation of MAPK activation is reinforced through pheromone-dependent mechanisms that directly affect the MAPK module enzymes themselves. Examples include dephosphorylation of the MAPKs by phosphatases, one of which is induced by pheromone, ubiquitin-dependent turnover of Ste11, which apparently depletes activated Ste11 from the Ste5-organized complex, and ubiquitination of Ste7 upon prolonged pheromone exposure (13, 21, 52, 54, 55, 58).
Pheromone induction also regulates the phosphorylation status of Ste7. Similar to other MAPKKs, Ste7 activation requires phosphorylation of two residues in the activation loop (20, 35, 59). In addition, both Fus3 and Kss1 mediate hyperphosphorylation of Ste7 in a feedback reaction that is contemporaneous with their activation (19, 20, 60, 61). Our group subsequently showed that Fus3 directly phosphorylates multiple residues in the Ste7 N-terminal regulatory domain and a single residue C-terminal to the catalytic domain (20; see also data in the supplemental material). Because Ste7 is also a direct substrate for Kss1, it is likely that both MAPKs target the same subset of residues (4).
Little is known about how feedback phosphorylation of Ste7 affects its activity and subsequent MAPK activation. Early observations indicated that the hyperphosphorylated Ste7 is less represented than the hypophosphorylated form in the Ste5-scaffold complex (8). Additionally, Ste7 in vitro kinase activity is significantly lower when the enzyme is isolated from cells expressing Fus3 and Kss1 than from cells lacking both MAPKs (19, 20). These observations suggest that feedback phosphorylation contributes to attenuation of signaling in the mating differentiation pathway. It has not been resolved whether the decrease in pheromone-stimulated Ste7 activity occurs because the hyperphosphorylated form has attenuated specific activity, is excluded from the interactions with components of the MAPK module, or is targeted for ubiquitination.
In this study we employed Ste7 activation loop and feedback phosphorylation site substitution variants to examine the above questions. We show that feedback phosphorylation of Ste7 does not attenuate its kinase activity nor influence its susceptibility to pheromone-induced ubiquitination. Unexpectedly, we found that constitutive Ste7 specifies an invasive response through selective activation of Kss1 and filamentation-specific gene expression. The selective transcriptional output occurs because mating-specific gene expression is suppressed through mechanisms that are dependent on the feedback phosphorylation status of Ste7.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. S. cerevisiae strains
|
|
View this table: [in a new window] |
TABLE 2. Plasmids
|
4::HisG) expressing STE7 alleles from plasmids as specified and MAT
tester strain KZ8-1D (50). As a control to confirm mating dependence of prototroph formation, parallel mating mixtures were made using MATa tester strain KZ8-5C. Semiquantitative comparisons were made as follows. Mid-log-phase cultures of tester strains were used to make grids with 106 cells per spot on complete medium (yeast extract-peptone-dextrose). Strains to be tested were grown to mid-log phase in selective medium (-Ura). Ten-fold dilutions were made and used for applying 105, 104, 103, and 102 cells from each culture to a tester strain spot on a grid on the solid medium. Mixtures were incubated at 30°C and then replica plated onto medium for selection of prototrophic diploids synthetic dextrose. Growth was scored after overnight incubation at 30°C. FUS1-lacZ expression is a standard reference for pheromone-induced and mating pathway-specific transcription (50). Reporter gene expression was measured by activity of the lacZ gene product (ß-galactosidase) in whole-cell extracts as previously described (40). Pheromone-induced G1 arrest was monitored by the percentage of unbudded cells in the sample by using a microscope and a hemacytometer grid to count cells. Pheromone-induced mating differentiation was monitored by the percentage of cells with mating projections using the same procedure. At least 200 individual cells were scored for each sample.
Invasive growth and filamentation reporter gene assays.
Growth chambers for visualizing invasive growth were made from two 3- by 1-in. glass microscope slides separated by a 5-mm-wide and 1.5-mm-thick U-shaped spacer. The spacer and slides were held in place using a 3/4-in.-wide binder clip at each end of the assembly. The chamber assemblies were autoclaved without media in glass petri dishes. Immediately before use, sterilized yeast extract-peptone-dextrose medium with 1.5% agar was liquefied by microwave heating and delivered into each sterilized assembly using a syringe with an 18-gauge needle. Cultures of strains to be tested were grown to mid-log phase in selective medium. A 25-µl aliquot of a 104 cell/ml dilution was applied to the solid medium in the trough between the microscope slides. After inoculation, the chambers were wrapped in saran, placed vertically in plastic boxes containing wet 3-mm paper to maintain humidity, and incubated at 30°C. After
48 h, images of colonies that grew beneath the agar surface were visualized using an Axioplan research microscope with a 2.5x objective. Images were captured using an Axio Cam camera with Zeiss Axiovision software. Images were taken at
4-mm intervals, allowing a sampling of 8 to 10 separate fields from each growth chamber. The areas of individual colonies from images at each interval were measured using NIH ImageJ software.
Ty-lacZ expression is a standard reference for filamentation pathway-specific transcription (31, 32, 34). The pNC343 plasmid version of this reporter that we employed has the composite Tec1 Ste12 binding element from Ty1 replacing the upstream activating sequence of the CYC1 promoter in pLG
178 (6, 29). This context differs from the TDH3 context of the FG-TyA-LacZ (pIL30) reporter that has been more generally used (30, 34). In our hands the FG-TyA-LacZ reporter has high basal expression compared with the pNC343 reporter plasmid. Additionally, the pNC343 Ty-LacZ reporter shows a more stringent dependence on components of the MAPK cascade, including Ste7 and Kss1. Reporter gene expression was measured by activity of the lacZ gene product (ß-galactosidase) in whole-cell extracts as previously described (40).
Immune precipitation kinase assays.
In vitro assays of Ste7 catalytic activity were performed directly on immune complexes of myc epitope-tagged Ste7 (Ste7M) with [
-32P]ATP and catalytically inactive Fus3-R42 as substrate. The source of Ste7M or variant proteins was from strain K2149 (bar1
FUS3 KSS1) or K2313 (bar1
fus3
kss1
) transformed with plasmids expressing Ste7M (or variants) from the CYC1 promoter. Strains were grown in selective medium (-Trp) to a density of
1 x 107 cells/ml. Samples were removed before and after 30 min of induction with mating pheromone (
-factor; 50 nM). Native protein extracts were prepared from samples as previously described (19). Fus3-R42 substrate polypeptide was prepared as a glutathione S-transferase (GST) fusion protein produced in Escherichia coli. The fusion protein was isolated on glutathione-agarose columns, eluted, and treated with thrombin to release the GST polypeptide as described elsewhere (49). The resulting mixture was used as substrate without further purification.
Immune complexes were isolated using buffers and wash conditions as previously described (19). For each assay we used 400 µg of extract with 22 µg of anti-myc 9E10 antibodies (22) and 50 µl of protein A-Sepharose beads (Pharmacia-LKB). These specific conditions were empirically determined to be in the linear range for activity versus immune complex (beads). Immune complex beads were suspended in 6 µl of kinase assay buffer (25 mM HEPES [pH 7.2], 15 mM MgCl2, 5 mM EGTA, 1 mM dithiothreitol, 0.1 mM orthovanadate, 15 mM 4-nitrophenylphosphate, 1 mM phenylmethylsulfonyl fluoride [PMSF], 2 µg of leupeptin per ml, 40 µg of aprotinin per ml). Approximately 250 ng of thrombin-treated GST-Fus3R42 substrate in a volume of 2 to 5 µl was added to the above suspension. The reactions were initiated by addition of an ATP mix (1 µl of 250 mM HEPES [pH 7.2], 2 µl of 1 mM ATP, 0.2 µl of [
-32P]ATP [10 µCi/µl; Dupont-NEN], 2.4 µl of 100 mM MgCl2) and water to give a final reaction volume of 20 µl. The mixtures were incubated at 30°C for 20 min, and reactions were terminated by addition of an equal volume of 2x sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) buffer and boiling for 3 min. Proteins in the reaction were fractionated by SDS-PAGE (7.5%). The portion of the gels that included the immune-precipitated Ste7 (above the 45-kDa molecular size marker) was transferred to nitrocellulose membranes for detection of the amount of Ste7M in the immune-precipitated complex with anti-myc antibodies. The lower portion of the gels that included Fus3-R42 and immunoglobulin chains was dried to determine the amount of 32P incorporated into Fus3-R42 by PhosphorImager analysis (Molecular Dynamics).
GST fusion protein copurification assays.
Either strain C699-92 (ste5
ste11
ste7
fus3
kss1
) or C699-93 (ste11
fus3
) was cotransformed with a plasmid for GAL1,10 promoter expression of one of the Ste7M phosphorylation site variant proteins (pNC809, pNC896, pNC897, pNC898, or pNC906) and GST (pEG-KT) or GST fusion proteins (pNC901, pNC903, pRD-GST-STE11 or pYBS293). Cultures of each cotransformed strain were grown in selective medium (-Trp -Ura) with raffinose (2%) as the carbon source. When cultures reached a density of
1 x 107 cells/ml, galactose (2%) was added to the medium to induce expression of the Ste7M variant and the GST fusion protein. After 6 h of induction, cultures were harvested and cell pellets were suspended in an equal volume of modified H-buffer (25 mM Tris [pH 7.4], 15 mM ethylene glycol tetraacetic acid [EGTA], 15 mM MgCl2, 1 mM dithiothreitol, 1 mM sodium azide, 0.1% Triton X-100) made with 10% glycerol and containing phosphatase and protease inhibitors (0.25 mM orthovanadate, 1 mM PMSF, and 5 µg each of pepstatin A, chymostatin, antipain, and aprotinin/ml). Cells in the suspensions were broken by vigorous shaking with an equal volume of glass beads on an IKA platform mixer at 4°C for a total of 12 min. Glass beads and cellular debris were removed by centrifugation at 4°C, and the supernatant was transferred to a new tube. The protein concentration of the resulting whole-cell protein extract was determined by the Bradford method using the Bio-Rad protein assay reagent.
GST fusion protein purifications were carried out using batch purification essentially as described by Choi et al. (8). In this study, 3 mg of protein extract was brought to a 300-µl final volume using modified H-buffer. A 20-µl sample was removed for immune blot analysis to determine the amount of GST fusion protein and Ste7 variant protein in the input fraction for each pull-down assay. The remaining sample was adjusted to 150 mM NaCl and 1% ovalbumin (or bovine serum albumin) and added to an Eppendorf tube containing 75 µl (packed volume) of glutathione agarose beads. Binding mixtures were incubated for 1 h at 4°C on a roller wheel. Beads were washed three times by addition of 1 ml of modified H-buffer made with 10% glycerol. After the final wash, beads were suspended in 40 µl of 2x SDS-PAGE buffer and boiled for 5 min. The protein supernatant was subjected to immune blot analysis to determine the amount of GST fusion protein and Ste7M variant protein in the eluant fraction for each pull-down assay.
Input and eluant samples were fractionated on duplicate gels by SDS-10% PAGE and transferred to nitrocellulose filters. One of the filters was probed for detection of the Ste7M variants by using the primary monoclonal anti-myc 9E10 antibodies (2.1 µg/ml). The duplicate filter was probed for detection of the GST fusion protein by using the primary monoclonal anti-GST antibodies (1:1,000; Promega). Secondary antibodies for both were goat anti-mouse immunoglobulin G (IgG)-alkaline phosphatase conjugate (1:7,000; Promega). Immunoreactive species on the blots were detected by colorimetric methods according to procedures detailed for the Promega Protoblot system. Signals from the scanned blots were quantified using NIH ImageJ software.
Immune blotting conditions for analysis of dual-phosphorylated Fus3M and Kss1M.
Strains C699-90 (ste5
ste7
fus3
kss1
) and C699-140 (ste7
fus3
kss1
) were transformed with plasmids for TPI1-promoted expression of myc-tagged Kss1 (Kss1M; pNC977) and/or myc-tagged Fus3 (Fus3M; pNC979). These two strains were also cotransformed with pRS313 and pRS316 to provide references for potential cross-reacting species. The resulting strains were then transformed with plasmids for CYC1-promoted expression of either wild-type Ste7 (pNC318), Ste7-EE-A7 (pNC597), or Ste7-EE-E7 (pNC893).
Cultures of each strain were grown in selective medium (-Trp -His and/or -Ura) with sucrose (1%) as the carbon source to a density of 5 x 106 cells/ml. A sample of the culture from strain C699-140 expressing wild-type Ste7 was used for the uninduced reference. The remaining portion of this wild-type Ste7 culture was pheromone induced by addition of
-factor (50 nM). Samples were removed after addition of pheromone for comparison of 10-, 15-, and 20-min induction times. Cells were harvested by centrifugation and suspended in lysis buffer [0.2 M Tris (pH 8.0), 0.4 M (NH4)2SO4, 1 mM EDTA (pH 8.0), 10% glycerol, 7 mM ß-mercaptoethanol, 1 mM orthovanadate, 1 mM PMSF, and 5 µg each of pepstatin A, chymostatin, antipain, leupeptin, and leupeptin/ml]. Cell lysis, extract preparation, and trichloroacetic acid precipitation were done according to procedures described by Sabbaugh et al. (44) except for the composition of the lysis buffer. Pellets from trichloroacetic acid precipitation were suspended and adjusted to a protein concentration of 7 µg/µl in 3x SDS-PAGE loading buffer and boiled for 10 min.
Samples were fractionated by SDS-PAGE on duplicate 10% gels and transferred to nitrocellulose filters. One filter was used for detection of the total amount of Fus3M and Kss1M with anti-c-myc goat polyclonal antibodies (Santa Cruz) at 0.2 µg/ml with rabbit anti-goat alkaline phosphatase-conjugated IgG (Santa Cruz) at 0.04 µg/ml. The duplicate filter was used to detect the fraction of dual-phosphorylated Fus3M and Kss1M by using anti-phospho p44/p42 MAPK rabbit polyclonal antibodies (Cell Signaling Technology) at a 1:500 dilution with goat anti-rabbit alkaline phosphatase-conjugated IgG (Santa Cruz) at 0.04 µg/ml. The anti-phospho p44/p42 MAPK rabbit polyclonal antibodies specifically recognize the dually phosphorylated forms of Fus3 and Kss1 (5, 44). Immunoreactive species were detected by colorimetric methods according to procedures detailed by the Promega Protoblot system. Signals from the scanned blots were quantified using NIH ImageJ software. The fold induction for phospho-Kss1 and phospho-Fus3 in each sample was determined by normalizing the ratio of the anti-p44/p42 signal to the anti-myc signal for each MAPK to the corresponding ratio for the uninduced reference sample.
Immune blotting conditions for detection of Ste7 phosphorylation and ubiquitination status.
Pheromone induction results in the accumulation of hyperphosphorylated Ste7, which has a 10-kDa-slower SDS-PAGE mobility than unphosphorylated Ste7 (61). To assess SDS-PAGE mobility, Ste7M and different substitution variants as specified were expressed from the CYC1 promoter in strain C699-89 (ste7
trp1-1) or C699-106 (ste7
trp1
::HIS3MX6). Eighty micrograms of each whole-cell extract was fractionated by SDS-10% PAGE and transferred to nitrocellulose. Ste7M and substitution variant proteins were detected by using goat anti-myc antibodies (Santa Cruz) at a 1:1,000 dilution with rabbit anti-goat alkaline phosphatase-conjugated IgG (Santa Cruz) at a 1:10,000 dilution. Immunoreactive species were detected by colorimetric methods according to procedures detailed for the Promega Protoblot system.
Ubiquitination of Ste7 results in the formation of a high-molecular-weight species (Ubi-Ste7) (54, 55). For detection of this species, wild-type Ste7 and Ste7 variant proteins were expressed from the STE7 promoter in strain YHD1001 (ste7
ubp3
) or from the CYC1 promoter in strain C699-32 (ste7
) expressing a dominant-negative form of Ubp3 (pYES-Ubp3C469S). Cells were grown to mid-log phase in selective medium (-Ura or -Trp), treated with 3 µM (for YHD1001) or 50 nM (for C699-32)
-factor for 1 h, lysed directly in SDS-PAGE buffer for fractionation by SDS-7.5% PAGE, and transferred to nitrocellulose. Membranes were developed by using primary anti-Ste7 antibodies (yN-18; Santa Cruz) at 1:200 dilution and secondary anti-goat IgG conjugated to horseradish peroxidase (Santa Cruz) at 1:6,000 dilution. Immunoreactive species were visualized using the enhanced chemiluminescence detection system (Pierce) as directed by the vendor.
|
|
|---|
![]() View larger version (42K): [in a new window] |
FIG. 2. Location of phosphorylation sites in Ste7 and SDS-PAGE mobility of variant proteins with phosphorylation site substitution mutations. (A) Residues phosphorylated in the activation loop of the catalytic domain (C) and feedback sites phosphorylated by Fus3/Kss1 in the regulatory domains (R). (B and C) Western blots show mobility of Ste7 species that are characteristic of hyperphosphorylated (HP-Ste7) or hypophosphorylated (Ste7) forms after SDS-PAGE fractionation of protein extracts from uninduced () or induced (+) cultures as indicated. Residues at the activation loop (Loop) and feedback (FB) sites denote the different Ste7 variants. Ste7M variants were expressed from the CYC1 promoter on plasmids in strain C699-89 (ste7 ) or C699-106 (ste7 ) using the following plasmids: pNC318 (Ste7M), pNC586 (Ste7M-A7), pNC892 (Ste7M-E7), pNC589 (Ste7M-EE), pNC597 (Ste7M-EE-A7), pNC893 (Ste7M-EE-E7), pNC571 (Ste7M-AA), pNC894 (Ste7M-AA-A7), and pNC895 (Ste7M-AA-E7).
|
MAPK-dependent hyperphosphorylation of Ste7 causes slow mobility of this species on SDS-PAGE (61). To assess whether glutamate and alanine substitutions at the feedback residues similarly confer conformations corresponding to hyper- and hypophosphorylated Ste7, respectively, we compared the SDS-PAGE mobilities of the variants to that of Ste7 from uninduced and pheromone-induced cultures (Fig. 2B and C). A single species with mobility identical to that of hyperphosphorylated Ste7 was observed for any variant with glutamate substitutions at the feedback residues, whether or not cultures were treated with pheromone (Fig. 2B and C, Ste7-E7, Ste7-AA-E7, and Ste7-EE-E7). Also, regardless of pheromone induction, a single species with mobility identical to that of hypophosphorylated Ste7 was observed for variants with alanine substitutions at the feedback residues (Fig. 2B and C, Ste7-A7, Ste7-AA-A7, and Ste7-EE-A7). The constitutively active and inactive variants with serine and threonine residues at the feedback sites also exhibited mobility on SDS-PAGE that was independent of pheromone induction. Ste7-EE induced Fus3/Kss1 activity and became hyperphosphorylated even in the absence of pheromone induction. Ste7-AA failed to stimulate Fus3/Kss1 activity above background and remained largely hypophosphorylated, even in the presence of pheromone induction (Fig. 2B and C, Ste7-EE and Ste7-AA). From these correlations, we infer that glutamate and alanine substitutions at the feedback residues correctly confer conformations corresponding to hyper- and hypophosphorylated Ste7, respectively.
MAPK-mediated feedback regulation of Ste7 activity.
Our group previously observed attenuation of Ste7 activity in cells expressing Fus3 and Kss1 compared with cells deficient in both MAPKs (19, 20). One explanation for the observation is that the specific activity of Ste7 is lower after feedback phosphorylation than before modification. To test this hypothesis, we compared in vitro kinase activity of the variant that cannot be phosphorylated at the feedback sites (Ste7-A7) to that of wild-type Ste7 and catalytically inactive Ste7-R220. For this comparison, myc epitope-tagged Ste7, Ste7-A7, and Ste7-R220 proteins were expressed from the CYC1 promoter and immune precipitated from extracts of uninduced or pheromone-induced cells either expressing Fus3 and Kss1 (FUS3 KSS1) or deficient in both MAPKs (fus3
kss1
). Assays were done directly in immune complexes using [
-32P]ATP with catalytically inactive Fus3 (Fus3-R42) as the protein substrate. Contrary to our prediction, Ste7-A7 had lower activity than the wild-type reference (Ste7) (Fig. 3A, lanes 5 and 6). Activity of Ste7-A7 was higher when isolated from fus3
kss1
cells than from FUS3 KSS1 cells (Fig. 3A, lanes 6 and 9). This activity was still lower than that of the wild-type reference in this background (Fig. 3A, lanes 8 and 9). These findings show that MAPK-dependent suppression of Ste7 activity occurs through a mechanism that is distinct from MAPK-catalyzed Ste7 feedback phosphorylation.
![]() View larger version (50K): [in a new window] |
FIG. 3. In vitro kinase activities of Ste7 phosphorylation site substitution derivatives. Upper panels show the PhosphorImage of 32P incorporation into Fus3R42, and lower panels show immune blots detecting immune-precipitated Ste7 after SDS-PAGE fractionation of proteins from immune complex kinase assay reactions. Cultures for these analyses were either untreated () or treated with pheromone (+), as indicated. Activities for each sample are calculated as ([32P]Fus3 signal)/(IP-Ste7 signal). The numbers below the immune blot report the activity for each reaction as a percentage of that obtained for the sample with pheromone-induced Ste7 (WT). (A) Samples in lanes 1 to 6 are from strain K2149 (FUS3KSS1), and those in lanes 7 to 9 are from strain K2313 (fus3 kss1 ) expressing catalytically inactive Ste7M-R220 (R220; pNC318-R220), wild-type Ste7M (Wt; pNC318), or Ste7M that cannot be feedback phosphorylated (A7; pNC586). (B) Samples in lanes 1 to 3, 6, and 7 are from strain K2149 (FUS3 KSS1), and those in lanes 4, 5, 8, and 9 are from strain K2313 (fus3 kss1 ) expressing Ste7M (Wt; pNC318), constitutively active Ste7M (EE; pNC589), or constitutively active Ste7M that cannot be feedback phosphorylated (EE-A7; pNC597).
|
kss1
background than with the FUS3 KSS1 background, because active Ste11 can accumulate in the former but not the latter (21). According to this model, the kinase activity of constitutive Ste7 variants should be independent of Fus3 and Kss1 genetic background, because they do not require modification by an upstream component for their activation. Therefore, we compared in vitro kinase activities of constitutive Ste7 derivatives that can and cannot be feedback phosphorylated using immune complex kinase assays as before.
As expected for a constitutive enzyme, Ste7-EE isolated from cultures without pheromone induction readily catalyzes phosphorylation of catalytically inactive Fus3 (Fus3-R42) (Fig. 3B, lane 2). The effect of pheromone induction on activity of the constitutive enzymes is minimal when isolated from either FUS3 KSS1 or fus3
kss1
cells (
2-fold or less) (Fig. 3B, compare lanes 2 and 3 with 6 and 7 and lanes 4 and 5 with 8 and 9). Constitutive Ste7 that is hyperphosphorylated (Ste7-EE) has higher activity than non-feedback-phosphorylated constitutive Ste7 (Ste7-EE-A7) (Fig. 3B, compare lanes 2 and 6 to lanes 3 to 5, 8, and 9). As seen with wild-type Ste7, feedback phosphorylation had a positive effect on the ability of constitutive Ste7 to phosphorylate Fus3-R42 in vitro. The comparisons made with Ste7-EE-A7, which eliminates the effect of feedback phosphorylation, showed that constitutive Ste7 has essentially the same activity regardless of pheromone induction and of FUS3 KSS1 genetic background (Fig. 3B, compare lanes 3, 5, 7, and 9). This outcome is consistent with the assessment that MAPK-dependent suppression of wild-type Ste7 activity occurs through attenuation mechanisms that target upstream components of the mating pathway.
Based on the above model, we infer that much of the Ste7 isolated from pheromone-induced FUS3 KSS1 cultures is still in the inactive state. Therefore, the amount of Fus3-R42 phosphorylation catalyzed by enzymes isolated from pheromone-induced fus3
kss1
cultures should be used to assess their relative specific activities. Using this criterion, the specific activity of Ste7 with glutamates at the activation loop was only 10 to 15% of that for Ste7 activated by phosphorylation (Fig. 3A and B, lanes 8 and 9). Yet, the amount of Fus3-R42 phosphorylation catalyzed in these in vitro reactions by constitutive Ste7 was similar to that for wild-type Ste7 isolated from pheromone-induced FUS3 KSS1 cultures (Fig. 3B, lanes 1, 2, and 6). Thus, despite low specific activity, expression of constitutive Ste7 from the CYC1 promoter yields a total activity comparable to what is achieved by the fraction of wild-type Ste7 that becomes activated during pheromone induction.
MAPK-mediated feedback regulation of Ste7 ubiquitination.
Recent studies revealed that Ste7 undergoes SCF (Skp1/Cullin/F-box)-dependent ubiquitination and proteosome-mediated degradation upon prolonged stimulation by pheromone (54, 55). To examine whether feedback phosphorylation or constitutive activity preferentially targets Ste7 for ubiquitination, we expressed wild-type Ste7 and different phosphorylation site variants from their own promoter in a mutant strain background known to accumulate ubiquitinated Ste7 (ubp3
) (54, 55). The ubiquitin-modified protein accumulates for wild-type Ste7 and for derivatives with serine and threonine at the activation loop, regardless of what residues are present at the feedback sites (Fig. 4A, lanes 1 to 3). The ubiquitin-modified species fails to accumulate for derivatives with either alanines or glutamates at the activation loop (Fig. 4A, lanes 4, 5, and 8 to 10). Therefore, the ubiquitin modification of Ste7 is dependent on phosphorylation at the activation loop but is independent of the feedback phosphorylation status of Ste7.
![]() View larger version (41K): [in a new window] |
FIG. 4. Ubiquitin modification of Ste7 phosphorylation site variants. Western blots show mobility of Ste7 species that are characteristic of the ubiquitinated (Ubi-Ste7), hyperphosphorylated (HP-Ste7), and hypophosphorylated (Ste7) forms. (A) Ste7 proteins were expressed from the STE7 promoter in strain YHD1001 (ste7 ubp3 ) by using plasmids pNC766 (Ste7M), pNC768 (Ste7M-EE), pNC770 (Ste7M-EE-A7), pNC791 Ste7M-EE-E7), pNC781 (Ste7M-AA-A7), or pNC790 (Ste7M-AA-E7). The same strain with vector (pRS316) was used as a negative reference. (B) Ste7 proteins were expressed from the CYC1 promoter in strain C699-32 (ste7 ) or strain C699-81 (ste7 ste11 ) carrying pYES-UBP3C469S by using plasmids pNC318 (Ste7M) or pNC597 (Ste7M-EE-A7). The same strain with vector (pNC160) was used as a negative reference.
|
and ste7
ste11
strains. Both strains also expressed a dominant-negative form of Ubp3 (Ubp3C469S) to allow accumulation and visualization of ubiquitinated species as before. Ubiquitinated Ste7 and ubiquitinated Ste7-EE-A7 were detected in the ste7
strain (Fig. 4B, lanes 2 and 3). However, the ratio of the ubiquitinated species to the unmodified species for Ste7-EE-A7 (0.08) was markedly less than that for the pheromone-induced wild-type Ste7 reference (0.31). The comparison in the ste7
ste11
strain was striking, because Ste7-EE-A7 became ubiquitinated in the absence of pheromone treatment and under conditions where wild-type Ste7 remained unmodified (Fig. 4B, lanes 5 and 6). The fraction of ubiquitinated Ste-EE-A7 (0.21) under these conditions was comparable to that for the pheromone-induced wild-type reference (0.31) (Fig. 4B, lanes 2 and 6). These results establish that Ste7 variants with glutamates at the activation loop are competent substrates for ubiquitination and that signal output from the pathway is required for the modification. Mating response and invasive growth phenotypes of Ste7 phosphorylation site variants. Ste7 mediates mating differentiation and invasive growth in haploid S. cerevisiae. To determine if expression of constitutive Ste7 and feedback phosphorylation influence the establishment of one or the other of these fates, we quantified mating and invasive phenotypes of strains expressing the different variants. For evaluation of mating pathway function, strains were compared for mating efficiency and pheromone-induced transcriptional, G1 arrest, and morphological responses (Fig. 5). A strain expressing a Ste7 variant (Ste7-N349) that is inactive because of an Asn substitution for a catalytically essential Asp residue was included as a negative control for these comparisons. As expected for catalytically inactive enzymes, the variants with Ala substitutions at the activation loop (Ste7-AA, Ste7-AA-E7, and Ste7-AA-A7) failed to mate and to support pheromone-induced responses (Fig. 5). The variants with Ser and Thr at the activation loop supported mating independently of the charge status of the feedback phosphorylation residues (Fig. 5A, Ste7, Ste7-E7, and Ste7-A7). These variants also functioned similarly with respect to the pheromone-induced reporter gene expression, G1 arrest, and mating projection formation (Fig. 5B and C).
![]() View larger version (29K): [in a new window] |
FIG. 5. Mating and pheromone response assays comparing the in vivo function of Ste7 phosphorylation site substitution derivatives. (A) Semiquantitative mating assays. Photographs show diploid colonies selected for growth on minimal medium after an overnight incubation of mating mixtures at 30°C. Tester strain KZ8-1D (MAT ; 106 cells) was mixed with the indicated number of cells from strain C699-89 (MATa bar1 ste7 ) with a plasmid expressing the specified Ste7 variant from the STE7 promoter. (B) Pheromone-induced reporter gene expression. The bar graph shows the average ß-galactosidase activity for expression of the mating-specific FUS1-LacZ reporter gene (pNC756) in two different strains carrying the specified Ste7 M variant expressed from the STE7 promoter. Averages are from four independent cultures of each variant in strain C699-89 (bar1 ste7 ) before ( ) 2-h induction with 50 nM -factor and from four independent cultures of each variant in strain MLY218a (MATa ste7 ) before ( ) and after ( -factor. Error bars show the average deviations in measurements. (C) Pheromone-induced G1 arrest and mating differentiation. The bar graph shows the average G1 arrest and mating differentiation indices for samples from the same cultures used to measure reporter gene expression in panel B. The G1 arrest index (C699-89 ]) is the percentage of unbudded cells in each culture after pheromone induction minus the percentage of unbudded cells in the starting vegetative culture. The differentiation index (C699-89 [ ]; MLY218a [
|
To examine the function of Ste7 phosphorylation site variants in the filamentous growth pathway, each variant was expressed in a ste7
strain derived from a background (
1278) that is competent for pseudohyphal and invasive growth. Cells were cultured using complex medium in chambers that allow direct microscopic visualization of colonies as they invade and grow beneath the agar surface (Fig. 6A). To quantify this response, we calculated the mean area of individual colonies below the agar surface. The average of the mean colony area from three independent experiments is shown (Fig. 6B).
![]() View larger version (26K): [in a new window] |
FIG. 6. Invasion assays comparing the in vivo functions of Ste7 phosphorylation site substitution derivatives. (A) Micrographs show invasive colonies from a section of growth chambers inoculated with strain MLY218a (ste7 ) carrying plasmids for expression of the Ste7 variants as specified in Fig. 4. (B) Bar graph shows the average and average deviation of the invasive colony mean area from three independent experiments. Measurements were made on 25 or more individual colonies in a given chamber after 46 to 48 h of growth at 30°C. Because few invasive colonies formed with the strains expressing the catalytically inactive Ste7M-N349 and Ste7M-AA variants, the values are an average from measurement of only 9 and 11 total colonies, respectively.
|
The above comparison shows that the constitutive Ste7 variants are functional under in vivo conditions, and it eliminates trivial explanations for their defective mating response phenotypes. Also, the failure to function in the mating pathway cannot be solely a function of strain background, because the constitutive variants were defective for mating responses in the same
1278 strain that was used for these invasion assays (Fig. 5B and C). Therefore, these observations establish that constitutive Ste7 uniquely specifies a filamentous growth response.
Constitutive Ste7 phosphorylates Kss1 but not Fus3 in vivo. Although constitutive Ste7 variants are functional kinases in vitro (Fig. 3), it is possible that their activity is insufficient to support high levels of active MAPK. In this case the observed signal specificity could simply be that a lower threshold of MAPK activation is needed for the invasion response than for the mating response. To examine this possibility, we used immune blot detection methods to compare the fraction of phosphorylated Fus3 and Kss1 that was sustained in vivo by constitutive Ste7 (Ste7-EE-A7 or Ste7-EE-E7) to that achieved by wild-type Ste7 during pheromone induction (5, 44). Fus3M and Kss1M were expressed from the constitutive TPI1 promoter in the strains used for this comparison. Because endogenous Fus3 (but not Kss1) expression is induced by pheromone, their expression from the TPI1 promoter ensured equivalent transcription of the two MAPKs independently of a mating pathway-induced response (16). Extracts of the different cultures were fractionated on duplicate gels by SDS-PAGE, which resolves Kss1 and Fus3, and transferred to nitrocellulose for immune blot analysis. Anti-myc antibodies were used on one filter to determine the total amount of Fus3M and Kss1M in each extract. The duplicate filter was used to detect the amount of dual-phosphorylated (pT-E-pY) Fus3M and Kss1M by using anti-phospho Erk antibodies (5, 44).
Normal pheromone induction leads to an increase in the relative amount of dually phosphorylated Fus3 and Kss1 (7, 44). Extracts of cultures expressing either Ste7-EE-A7 or Ste7-EE-E7 without pheromone induction were compared directly to those from the uninduced (t = 0) and pheromone-induced (t = 15 min) wild-type Ste7 reference (Fig. 7A ). Constitutive Ste7 promoted in vivo phosphorylation of Kss1 to levels that were as high or higher than those seen for the pheromone-induced reference (Fig. 7A and D). By contrast, there was no increase in Fus3 phosphorylation above the basal levels seen for the uninduced reference (Fig. 7A and D). We also examined Kss1M phosphorylation when coexpressed with Ste7-EE-A7 or Ste7-EE-E7 in the absence of Fus3. We found that constitutive Ste7 promoted levels of phospho-Kss1 that were lower in the absence than in the presence of Fus3. But the amount of phospho-Kss1 was nevertheless comparable to the pheromone-induced levels (Fig. 7A, lanes 4, 5, 7, and 8, and D). The amount of phospho-Fus3 remained at the basal levels seen for the uninduced reference whether or not Kss1 was also present (Fig. 7A and D). Similar results were seen with extracts from the corresponding ste5
strains (Fig. 7B, C, and D). These results showed that the ability of constitutive Ste7 to phosphorylate Kss1 is independent of the scaffold-Ste5. They also suggest that Fus3 has some positive role in allowing hyperaccumulation of phosphorylated Kss1. The finding that constitutive Ste7 promotes high levels of phospho-Kss1 rules out the possibility that the substitution variants of Ste7 are ineffective kinases in vivo. Further, the activation of Kss1 is consistent with the observed stimulation of an invasive response by constitutive Ste7.
![]() View larger version (23K): [in a new window] |
FIG. 7. Comparison of Fus3 and Kss1 phosphorylation induced by pheromone or constitutive Ste7. (A to C) The upper panel shows the total amount of Fus3M and Kss1M by detection with anti-myc antibodies. The lower panel shows the fraction of dually phosphorylated Fus3M and Kss1M by detection with anti-Erk (pT-E-pY) antibodies. The signals corresponding to Kss1M (K) and Fus3M (F) are indicated to the right of the blots. (A) Protein extracts (33 µg) were from strain C699-140 (STE5 ste7 fus3 kss1 ) expressing wild-type (Wt) Ste7 (pNC318), Ste7-EE-A7 (pNC597), or Ste7-EE-E7 (pNC893) with Kss1M (pNC977), Fus3M (pNC979), or both, as indicated. Lanes 1 and 2 show extracts from the Wt-Ste7 strain before () and after (+) 15-min pheromone ( -fr; 50 nM) induction. (This time was empirically shown to result in optimal induction of Fus3 and Kss1 phosphorylation.) Lane 9 shows an extract from the Ste7-EE-E7 strain with vectors (pRS313 and pRS316) as a negative reference. (B and C) Lanes 1 and 2 show extracts (66 µg) from strain C699-140 (STE5 ste7 fus3 kss1 ) expressing Wt-Ste7 with Kss1M and Fus3M before () and after (+) induction with pheromone as specified in panel A. Lanes 3 and 4 (B) or 3 to 5 (C) show extracts (33 µg) from strain C699-90 (ste5 ste7 fus3 kss1 ) expressing Ste7-EE-A7 or Ste7-EE-E7 with Kss1M, Fus3M, or both as specified. Lane 6 (C) shows an extract from strain C699-90 expressing Ste7-EE-A7 with vectors (pRS313 and pRS316) as a negative reference. (D) Bar graph comparing the relative fold induction of phospho-Kss1 (
|
Phosphorylation status of Ste7 determines its selective binding to components of the MAPK activation module. To delineate how constitutively active Ste7 selectively phosphorylates Kss1 in vivo, we compared Ste7 variants for relative binding to each of the relevant components of this pathway by using a standard GST fusion protein copurification assay. We limited the comparison to those variants that represent the four possible combinations of loop and feedback site phosphorylation states of Ste7 (Ste7-AA-A7, Ste7-EE-A7, Ste7-AA-E7, and Ste7-EE-E7). This selection was made to ensure that the population of Ste7 species in different binding reactions would be homogenous and unaffected by the spurious actions of phosphatases or kinases. Additionally, the substitution variants allow assessment of interactions with species of Ste7 that would otherwise be transient and thus of too low abundance to be detected in comparisons of wild-type Ste7 from uninduced and pheromone-induced extracts.
A host strain that is deficient in all MAPK module components (ste5
ste11
ste7
fus3
kss1
) was used so that only pairwise interactions would be assessed. (The exception was for comparisons of Ste7 binding to GST-Ste5 [see below].) The GST fusion proteins and the myc-tagged Ste7 variant proteins in the input and eluant fractions of these assays were detected by using anti-GST antibodies and anti-myc antibodies, respectively (Fig. 8). Relative binding efficiencies are reported as the ratio of the anti-myc signal to the anti-GST signal in the eluant fraction. Because there was no binding of Ste7 variants to GST alone, the presence of Ste7 in an eluant fraction was due to its binding to the specified MAPK pathway component (Fig. 8E). For reference, the magnitude of the relative binding of Ste7-AA-A7 to each of the GST fusion proteins reported below was the same or slightly greater than what we observed for wild-type Ste7 in the corresponding strains (data not shown.)
![]() View larger version (33K): [in a new window] |
FIG. 8. Copurification assays comparing the in vivo binding of Ste7 phosphorylation site substitution derivatives to other components of the MAPK activation module. Representative Western blots show the amount of indicated Ste7 variant and GST fusion protein in the starting extracts (Input) and in the glutathione-agarose-immobilized fraction (Eluant). Proteins were fractionated by SDS-PAGE. Monoclonal anti-myc 9E10 antibodies were used for detection of myc epitope-tagged Ste7 (Ste7M) derivatives, and monoclonal anti-GST antibodies were used for detection of GST or the indicated GST fusion protein. Bar graphs show the average relative binding and average deviation for the specified Ste7M variant and GST fusion protein. Relative binding is the ratio of the anti-myc signal (Ste7) to the anti-GST signal (fusion protein) in the eluant fraction. (A) Strain C699-93 (ste11 fus3 ) was used to coexpress each Ste7M variant with GST-STE5 (pYBS298). Strain C699-92 (ste7 ste5 ste11 fus3 kss1 ) was used to coexpress each Ste7M variant with the following: GST-STE11 (pRD-GST-Ste111-717) (B); GST-FUS3 (pNC901) (C); GST-KSS1 (pNC903) (D); or GST (pEG-KT) (E). Indicated Ste7M variant proteins were expressed using the plasmids pNC896 (Ste7M-AA-A7), pNC897 (Ste7M-EE-A7), pNC898 (Ste7M-AA-E7), and pNC809 (Ste7M-EE-E7).
|
fus3
) to coexpress GST-Ste5 with the different Ste7 variant proteins. Under these conditions we found that Ste7-AA-A7, Ste7-EE-A7, and Ste7-AA-E7 bound equally well to Ste5 but Ste7-EE-E7 bound less effectively (Fig. 8A). The latter observation is consistent with the report that hyperphosphorylated wild-type Ste7 binds poorly to Ste5 (8). However, the inactive but hyperphosphorylated Ste7 variant (Ste7-AA-E7) binds to Ste5 as well as the variants without charge at the feedback phosphorylation sites. To reconcile this observation with that of Choi et al. (8), we assume that inactive but hyperphosphorylated Ste7 is a minor species in the wild-type population. The relatively poor binding of Ste7-EE-E7 to Ste5 could contribute to inefficient colocalization with Fus3. This deficiency could explain the failure of Ste7-EE-E7 to phosphorylate Fus3 in vivo. However, we note that Ste7-EE-A7 binds well to Ste5 even though this variant also fails to phosphorylate Fus3 in vivo (Fig. 7). These results suggest that simply tethering Ste7 on the scaffold is not sufficient to ensure effective phosphorylation of Fus3 (see below). All four Ste7 phosphorylation site substitution variants bound to the MAPKKK-Ste11 (Fig. 8B). In principle, the binding of Ste11 to constitutive forms of Ste7 could negatively affect signaling by competing with the MAPKs for access to Ste7. However, it is unclear whether this potential competition would be significant in the scaffold-organized complex.
The most surprising finding is that the phosphorylation state dependence of Ste7 binding to the MAPK-Fus3 is different from that for binding to the MAPK-Kss1. All four Ste7 phosphorylation site substitution variants bound similarly to Kss1 (Fig. 8D). By contrast, the strongest binding to Fus3 was seen with Ste7-AA-A7, which represents inactive Ste7 without feedback phosphorylation (i.e., naïve Ste7) (Fig. 8C). Ste7-EE-A7 essentially showed no binding to Fus3 (Fig. 8C). This variant can be thought of as the transition state intermediate on the pathway from active Ste11 to active Fus3 and Kss1. The failure of this intermediate to bind to Fus3 reveals that the scaffold-Ste5 probably provides the major route for colocalizing active Ste7 with Fus3. The binding characteristics of the different Ste7 variants are also consistent with Ste5 being dispensable for the activation of Kss1 by Ste7.
Constitutive Ste7 variants promote high levels of filamentation-specific reporter gene expression.
Invasive growth and Kss1 activation promoted by constitutive Ste7 predict that these variants should stimulate filamentation-specific gene expression above the basal levels seen in a wild-type Ste7 background. To confirm this prediction, we measured expression of a filamentation-specific reporter gene in ste7
, ste7
fus3
, and ste7
kss1
strains that expressed Ste7 and variant proteins from the CYC1 promoter. The reporter gene (Ty-LacZ) for this comparison uses a Tec1-Ste12 composite binding site derived from the Ty1 sequence to drive LacZ expression (Fig. 1) (6).
Consistent with this prediction, constitutive Ste7 variants promoted 9- to 20-fold-higher ß-galactosidase activities relative to the amount promoted by the wild-type Ste7-reference (Table 3, strain C699-106). In a strain deficient in the MAPK-Kss1, reporter gene activity remained at background amounts whether or not the strain expressed wild-type or constitutive Ste7 variants (Table 3, strain C699-146). This outcome is consistent with the effects of constitutive Ste7 being mediated by phosphorylation and activation of Kss1. Deleting the mating pathway-specific MAPK-Fus3 significantly enhances Ty-LacZ expression promoted by the wild-type Ste7 but not by constitutive Ste7-variants (Table 3, strain C699-145). The negative effect that Fus3 had on Ty-LacZ expression in the wild-type Ste7 strain is consistent with previously reported findings (5, 32, 44, 57). The finding that Fus3 has no dramatic effect on output from constitutive Ste7 variants could be either because Fus3 does not accumulate in the activated state in these strains or because hyperactivation of Kss1 is sufficient to overcome any negative effects that active Fus3 mediates.
|
View this table: [in a new window] |
TABLE 3. Ste7-promoted reporter gene expression in strains with deletions of MAPK activation module components
|
3-fold greater in the fus3
strain compared with the FUS3 strain (Fig. 9). The constitutive Ste7 variants also showed a more robust invasion phenotype in fus3
strains compared with FUS3 strains (Fig. 9). This result shows that Fus3 has a more negative effect on invasion compared with the Ty-LacZ reporter gene expression. We infer that other branches of the pseudohyphal network (and/or downstream events required for invasion) are more sensitive than the transcriptional output to inhibitory effects of Fus3.
![]() View larger version (33K): [in a new window] |
FIG. 9. Invasion assays comparing wild-type and constitutive Ste7 variants in FUS3 and fus3 genetic backgrounds. (A) Micrographs show invasive colonies from a section of the invasion chambers inoculated with strain MLY218 (FUS3 ste7 ) or SM002 (fus3 ste7 ) carrying plasmids for expression of wild-type (Wt) Ste7 (pNC766), Ste7-EE-A7 (pNC770), Ste7-EE-E7 (pNC791), or catalytically inactive Ste7-N349 (pNC771) as indicated. (B) Bar graph shows the average and average deviation of the invasive colony mean area from three independent experiments. Measurements were made after 46 to 48 h of growth at 30°C. The number of colonies measured in each experiment depended on the Ste7 variant and FUS3 background. Chambers of the FUS3 strain with functional Ste7 variants contained 29 to 127 invasive colonies; those of the corresponding fus3 strain contained 53 to 230 invasive colonies. Chambers of the negative reference (Ste7-N349) strains contained 7 to 27 invasive colonies.
|
To make this test, wild-type and constitutive Ste7 variants were expressed from the CYC1 promoter in ste7
strains that also had deletions of other MAPK activation module components. ß-Galactosidase activity was measured to assess pheromone-independent activation of a mating pathway reporter gene (FUS1-LacZ). This reporter uses the previously described upstream activating sequence from the FUS1 promoter that encompasses three Ste12 binding sites to drive LacZ expression (Fig. 1) (18). Pheromone-treated ste7
FUS3 KSS1, ste7
fus3
KSS1, and ste7
FUS3 kss1
cultures expressing wild-type Ste7 were included in the comparison to establish reference values for induced reporter gene activation in the three different MAPK genetic backgrounds.
Pheromone treatment of a wild-type strain caused a 3,000-fold increase in reporter gene expression compared with the reference strain lacking Ste7 (Table 3, strain C699-32, pNC318 Ste7 induced, compared with strain C699-32, pNC160). Only the constitutive Ste7 variant that cannot be feedback phosphorylated (Ste7-EE-A7) promoted FUS1-lacZ expression above the background amount (Table 3, strain C699-32, pNC597, compared with strain C699-32, pNC160). Deletion of certain components of the MAPK activation cascade further enhanced this activity. Eliminating the MAPK-Fus3 or the MAPKKK-Ste11 allowed significant enhancement of Ste7-EE-A7-promoted reporter gene expression above that in the otherwise wild-type background (Table 3, pNC597 data for strains C699-81 and C699-80 compared with data for strain C699-32). These findings showed that Ste11 and Fus3 are negative regulators of constitutive mating pathway transcription. Ste7-EE-A7 failed to promote reporter gene expression above background amounts in the corresponding strains expressing Fus3 but lacking Kss1 (Table 3, pNC597, strains C699-114, C699-116, and C699-115). This outcome corroborates the finding that Ste7-EE-A7 fails to phosphorylate and activate Fus3 in vivo (Fig. 7). This outcome further shows that Kss1 is the sole mediator of any transcriptional response promoted by Ste7-EE-A7.
The most striking finding was that Ste5 and Fus3 synergistically mediate inhibition of mating-specific gene expression. Eliminating both Ste5 and Fus3 allowed Ste7-EE-A7 to promote reporter gene expression that was
5-fold higher than that seen for pheromone-induced Ste7 in the fus3
reference strain (Table 3, pNC597, strain C699-87 versus pNC318 induced, strain C699-80). This synergism was not a simple consequence of deleting two components with negative effects, because eliminating Ste11 and Fus3 or Ste5 and Ste11 had greater no greater effect than eliminating Ste11 alone (Table 3, pNC597, strains C699-81, C699-127, and C699-108). These findings suggest that the scaffold-Ste5 and the MAPK-Fus3 collaborate in a mechanism that restricts mating pathway output under conditions of persistent Kss1 activation. This collaborative mechanism is notable because these are the two components that distinguish the mating pathway from the invasive growth pathway.
We observed that constitutive Ste7 variants with and without charge at the feedback sites promote comparable levels of phospho-Kss1 (Fig. 7). Thus, it is perplexing that the constitutive variants with negative charge at the feedback sites (Ste7-EE or Ste7-EE-E7) remained defective for promoting FUS1-lacZ expression even in the deletion strains that expose activity promoted by Ste7-EE-A7 (Table 3, pNC597, pNC589, and pNC893 versus pNC160). This outcome points to an inhibitory mechanism imposed by Ste7-EE-E7 that is independent of Fus3 and Ste5. Thus, two distinct mechanisms act to selectively block transcription from mating-specific genes. Whether the Ste5- and Fus3-mediated mechanism or Fus3- and Ste5-independent mechanism is predominant depends on whether constitutive Ste7 is without or with charge at the feedback sites. The potential relevance for the existence of two different inhibitory mechanisms is discussed below.
|
|
|---|
Constitutive Ste7 selectively activates Kss1. We found a direct correlation between phospho-MAPK levels in vivo and the ability of different constitutive Ste7 variants to bind to Fus3, Kss1, and Ste5 (Table 4). The correlations suggested that activation of Fus3 in vivo requires binding to both Ste7 and the scaffold-Ste5 but that activation of Kss1 is independent of Ste5. Constitutive Ste7 with or without negative charge at the feedback sites (Ste7-EE-E7 and Ste7-EE-A7) promoted accumulation of phospho-Kss1 in vivo independently of Ste5. Also, both Ste7-EE-E7 and Ste7-EE-A7 bound well to Kss1. Neither Ste7-EE-A7 nor Ste7-EE-E7 promoted accumulation of active phospho-Fus3 in vivo. Ste7-EE-A7 bound to Ste5 but did not bind to Fus3. Ste7-EE-E7 bound to Fus3 but interacted poorly with Ste5. Taking mass action into account, we expect the equilibrium distribution of Ste7-EE-E7 expressed from either the CYC1 or endogenous promoter would favor a pool that is localized away from the Ste5 complex. Thus, both forms of constitutive Ste7 miss one or the other of the two binding interactions that we postulate is crucial for efficient Fus3 phosphorylation and activation.
|
View this table: [in a new window] |
TABLE 4. Summary of activities promoted by constitutive Ste7 variants
|
The differential amounts of active Kss1 and Fus3 reflect not only differences in their phosphorylation by constitutive Ste7 but also potential differences in dephosphorylation by phosphatases. Msg5 is a dual-specificity MAPK phosphatase that regulates Fus3 and Kss1 through dephosphorylation of the phospho-tyrosine and phospho-threonine residues at their activation loop (11, 13). Andersson et al. (1) recently reported that Msg5 selectively inhibits Fus3 under basal conditions where signal intensity is low. Therefore, it is likely that Msg5 contributes to maintaining low basal levels of phopsho-Fus3 under conditions of inefficient activation by the constitutive Ste7 variants.
Implications for Ste7 function on the Ste5-scaffold during pheromone-induced signaling. Constitutive Ste7 variants with or without negative charge at the feedback sites (Ste7-EE-E7 and Ste7-EE-A7) are defective for activating Fus3 and sustaining mating responses. By contrast, their counterparts that have serine and threonine residues at the activation loop (Ste7-E7 and Ste7-A7) function indistinguishably from wild-type Ste7 and, therefore, must efficiently activate Fus3 in vivo. We conclude from this contrasting behavior that the glutamate substitutions at the activation loop and not the phosphorylation status of Ste7 feedback sites are responsible for the failure of the constitutive variants to activate Fus3.
A higher specific activity of phospho-Ste7 compared with the glutamate-mimic could explain different efficiencies of Fus3 activation in vivo. Yet, differences in specific activity of the inducible and glutamate derivatives have little effect on levels of Kss1 activation in vivo. Therefore, we believe a more important consideration is whether a Ste7 variant can function properly on the scaffold to phosphorylate Fus3. In contrast to the active Ste7 mimics, Ste7-AA-A7 (which mimics naïve Ste7) and Ste7-AA-E7 (which mimics feedback-phosphorylated but inactive Ste7) efficiently bind to both Fus3 and Ste5. Thus, the requirements for function on the scaffold could be satisfied for Ste7-A7 and Ste7-E7 in their naïve state or after dephosphorylation at the activation loop. The failure of glutamate substitution counterparts to activate Fus3 could be viewed as a consequence of their being impervious to phosphatases and thus unable to achieve the correct stereochemical orientation for activation of Fus3 on the scaffold.
This interpretation for function of phospho-Ste7 compared with the glutamate-mimic suggests the following model for activation of Fus3 during normal pheromone induction (Fig. 10). We propose that pheromone stimulates the recruitment of inactive Ste7 and other core enzymes of the mating pathway cascade to the scaffold complex for activation by upstream components (Fig. 10A). This recruitment allows Ste7 to make the contacts with Ste5 and Fus3 that are necessary for the correct stereochemical orientation of the scaffold assembly (Fig. 10B). This configuration is compatible with Ste11 activation of Ste7 and subsequent efficient activation of Fus3. Upon MAPK activation, feedback phosphorylation of active Ste7 promotes its dissociation from the scaffold (Fig. 10C). An implication of this model is that continuous recruitment of naïve Ste7 to the scaffold or action of a Ste7 phosphatase would be critical for sustaining the ability of Ste7 to continue activating Fus3.
![]() View larger version (35K): [in a new window] |
FIG. 10. Model for regulation of the mating pathway MAPK cascade. See text for explanation.
|
Constitutive Ste7 promotes invasion and a filamentation-specific transcriptional output. Genome-wide expression profiles of pheromone-induced strains deficient in either Fus3 or Kss1 provide evidence that either MAPK is sufficient to promote the mating transcriptional program through activation of Ste12 (7, 41). However, the two MAPKs have different effects on Ste12-mediated induction of the filamentation transcription program (57). The kinase activity of Fus3, but not Kss1, prevents Ste12 from binding to filamentation-specific genes in pheromone-stimulated cells (32, 44, 57). The inhibitory effects of Fus3 at these promoters are dependent on Tec1 (32, 44, 57). Our analyses suggest the existence of at least two reciprocal mechanisms that prevent Ste12 from acting at mating-specific genes under conditions that otherwise promote an invasive growth response.
The finding that overproduction of the constitutive Ste7 without feedback phosphorylation (Ste7-EE-A7) restored expression of a mating pathway reporter gene opened avenues for us to identify components that suppressed Kss1-mediated activation at these promoters. The comparison revealed that Ste7-EE-A7 in a ste5
fus3
double mutant background promoted levels of FUS1-lacZ that were even greater than what is typically seen for a pheromone-induced wild-type reference strain (Tables 3 and 4). While essential for mating responses, Ste5 and Fus3 are not required for the invasive response (42). Thus, it appears these mating pathway-designated components can limit a mating response under conditions where Kss1 accumulates in the active form but Fus3 activity remains at basal levels. The pool of inactive Fus3 could interfere with active Kss1 by binding to common downstream targets, such as the Ste12-Rst1/2 (Dig1/2) transcription complex (5, 10, 17, 32, 51). Alternatively, the basal activity of Fus3 could be sufficient to modify components of the mating-specific promoter complex in a way that prevents activation at these promoters. Although there is no evidence for the scaffold-Ste5 participating in either process, such a role would explain the synergistic effect of eliminating both Fus3 and Ste5.
Ste7-EE-A7 is essentially equivalent to Ste7-EE-E7 with respect to promoting Kss1 activation and filamentation-specific gene expression, but the mechanism responsible for suppression of mating-specific gene expression is different for the two constitutive Ste7 variants. In contrast to the outcome for Ste7-EE-A7, there was no activation of FUS1-LacZ expression promoted by Ste7-EE-E7 in the ste5
fus3
background (Tables 3 and 4). This result rules out a Fus3- and Ste5-mediated mechanism as the sole means for transcriptional suppression at mating-specific promoters in strains expressing Ste7-EE-E7. We speculate that a separate Ste7-EE-E7-dependent effect predominates in this circumstance and that it may involve a binding and/or substrate specificity that pertains only to active Ste7 with charge at the feedback sites. For example, because of this postulated specificity, Ste7-EE-E7 might modify the localization or activity of yet-to-be identified targets that mediate the inhibition at mating-specific genes.
The Ste5- and Fus3-dependent and -independent mechanisms for suppressing transcription at mating-specific promoters may be important under different physiological conditions where one or the other feedback form of Ste7 is predominant. For example, Ste5 and Fus3 may contribute to maintaining a low transcriptional output from the mating pathway under basal conditions where feedback-phosphorylated Ste7 does not accumulate. By contrast, suppression mediated by the Ste5- and Fus3-independent mechanism may be more important for inhibiting mating output when the invasive pathway is stimulated and there is likely to be a persistent and high level of active and feedback-phosphorylated Ste7.
This work was supported by NIH grants GM39852 (B.E.) and GM 5059167 (H.G.D.) and by American Heart Association fellowship 02253390U (Y.W.).
Supplemental material for this article may be found at http://mcb.asm.org/. ![]()
Present address: Cell Signaling Technology, Inc., Beverly, MA 01915. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»